Euroelso Associates

Quick Stats

• Charity Number: 1153778
• Annual Giving: Up to €60,000 (4 grants annually)
• Grant Range: Up to €15,000 per grant
• Decision Time: Approximately 2 months from deadline
• Geographic Focus: Europe (must be active ELSO centre or affiliated)
• Application Schedule: Annual call (typically deadline December 15)

Contact Details

Website: www.euroelso.net

Email: euroelso@interplan.de (grant applications and enquiries)

UK Registered Address: Freeman Hospital, Freeman Road, High Heaton, Newcastle upon Tyne, NE7 7DN

Operational Office: INTERPLAN Congress Meeting & Event Management AG, Sachsenstraße 6, 20097 Hamburg, Germany

Phone: +44 191 232 8065

Overview

EUROELSO ASSOCIATES is a UK registered charity (established 2013) that serves as the charitable arm of EuroELSO, the European Branch of the Extracorporeal Life Support Organization. The charity's mission is to advance and promote the relief of critical illness across Europe through the development and evaluation of novel therapies for patients with severe respiratory or cardiac failure using extracorporeal support. EuroELSO supervises scientific initiatives to promote multidisciplinary ECLS (extracorporeal life support) application, investigation, research, education and training in Europe. The organization awards up to €60,000 annually through four research and education grants, with calls typically occurring once per year. EuroELSO brings together European healthcare professionals and scientists dedicated to advancing extracorporeal life support technologies and improving patient outcomes in critical care.

Funding Priorities

Grant Programs

EuroELSO Grants for Research and Education

• Maximum grant value: €15,000 per project
• Four grants available annually
• At least one grant for paediatric practice
• At least one grant for adult practice
• Project duration: 18 months
• Application method: Email submission to euroelso@interplan.de
• Annual application deadline: December 15

Priority Areas

EuroELSO funds research and educational projects aligned with advancing critical illness care through extracorporeal support. Key focus areas include:

Research Priorities:

• ECMO (extracorporeal membrane oxygenation) and ECLS clinical studies
• Novel therapies for severe respiratory failure
• Novel therapies for cardiac failure requiring extracorporeal support
• Immunothrombosis and thrombotic complications in ECMO patients
• Geospatial analysis of ECMO provision in Europe
• Transfusion requirements in ECMO
• Temperature-empowered extracorporeal CO2 removal

Working Group Themes:

• Infection in ECLS
• Sustainability in extracorporeal therapies
• Rehabilitation post-ECMO
• Normothermic Regional Perfusion (EISOR)
• Neurological outcomes
• Simulation and artificial intelligence in ECMO
• Haematological impact of ECMO
• Transport and ECMO
• ECPR (extracorporeal cardiopulmonary resuscitation)
• Innovation in ECMO technology (pumps, oxygenators, cannula designs, biocompatibility)
• Septic shock management with ECLS

Educational Priorities:

• Development of educational content and resources
• Training programs for medical professionals
• Standardization of ECMO education across Europe
• Community education on extracorporeal therapies

What They Don't Fund

• Projects extending beyond 18 months
• Additional costs not outlined in the original application
• Projects from institutions not affiliated with active ELSO centres
• General operating costs unrelated to the specific research or education project

Ready to write a winning application for Euroelso Associates?

Our AI helps you craft proposals that match their exact priorities. Save hours and increase your success rate.

Learn more >

Governance and Leadership

Current Steering Committee Officers

Chair: Justyna Swol (Germany)

Deputy Chair: Mirjana Cvetkovic (United Kingdom)

Past Chair: Nicholas Barrett (London, United Kingdom)

Honorary Secretary: Roberto Lorusso (Maastricht, The Netherlands)

Steering Committee Members

The committee includes representatives from across Europe: Jana Assy (Belgium), Mark Davidson (UK), Jo-anne Fowles (UK), Aparna Hoskote (UK), Sharon Jakobs (Belgium), Annemieke Oude Lansink-Hartgring (Netherlands), Matthias Lubnow (Germany), Malaika Mendonca (Switzerland), Mateusz Puslecki (Poland), Jordi Riera (Spain), Peter Roeleveld (Netherlands), Konstanty Szuldrynski (Poland), Leen Vercaemst (Belgium), and Soňa Wulczyňská (Czech Republic).

Notable Leadership Background

Roberto Lorusso served as Euro-ELSO Conference Chair from 2012-2014 and as Euro-ELSO Chair from 2015-2018, providing continuity and strategic direction to the organization's grant-making activities.

Application Process and Timeline

How to Apply

Application Method: Email submission

Submission Address: euroelso@interplan.de

Application Deadline: December 15 annually

Application Form: Available on the EuroELSO website (www.euroelso.net/euroelso-grants/)

Required Information:

• Lead applicant details
• Detailed project description with character limits for specific sections
• Healthcare or educational need (maximum 1,000 characters)
• Breakdown of resources requested with costs including locally paid taxes
• Optional: Two additional A4 pages (one for references, one for tables/figures)

Pre-Application Requirements: None specified, but applicants must confirm that their host institution is an active ELSO centre or affiliated with one.

Decision Timeline

• Application Deadline: December 15
• Evaluation Panel Convened: Within 2 months of closing date (typically mid-February)
• Decision Notification: Within 10 calendar days of evaluation panel meeting
• Announcement: Results typically announced at the annual EuroELSO Congress (usually April)
• Total Timeline: Approximately 2-3 months from submission to notification

Example Timeline: For the 2022-2023 cycle, the application deadline was March 19, 2023, and successful grants were announced at the congress in Lisbon on April 26-29, 2023.

Success Rates

Specific success rate percentages are not publicly disclosed. However, with four grants available annually and typically one annual call, competition is significant. Applications undergo rigorous peer review by at least three assessors.

Reapplication Policy

• Unsuccessful applicants receive feedback within 10 calendar days of the evaluation panel
• No explicit restrictions on reapplication mentioned
• Feedback is provided to support improved future applications
• However, note that for previous grant recipients, "failure to present an abstract within 2 years could penalize future applications from the candidate's research team"

Application Success Factors

Lead Applicant Evaluation (Scored 1-10)

The evaluation panel looks for applicants who demonstrate:

• Track record: “A potential or proven track record to deliver the project successfully”
• Previous EuroELSO engagement: Details of any previous EuroELSO funds received, including completion status, publications, or presentations at EuroELSO meetings
• Strong professional credentials in ECMO/ECLS field

Research Project Evaluation Criteria (Each Scored 1-10)

Healthcare Need and Rationale: Clearly articulate the clinical problem and why this research matters

Originality: Demonstrate that your project fills a gap - assessors check for “overlap with existing/ongoing research”

Project Plan and Experimental Design: Must be robust and detailed, showing you've thought through methodology

Statistical Analysis: Must be appropriate and clearly demonstrate “whether the study will answer the question”

Budget Justification: Show that “sufficient resources are requested to complete the project” and that “resources requested are justifiable”

Educational Project Evaluation Criteria (Each Scored 1-10)

• Educational need
• Originality and overlap with existing/ongoing projects
• Project plan quality
• Likelihood of project completion
• Expected beneficiaries and impact

Evaluation Process Insights

• Minimum three assessors review each application independently
• Assessors score criteria 1-10 and provide narrative support
• Mean scores presented to evaluation panel
• Evaluation committee “moderates these grades paying particular attention to cases where there is a divergence of the assessment”
• Panel typically chaired by Honorary Chairman of EuroELSO Associates or Steering Committee nominee
• All panel members must declare conflicts of interest
• Decisions are final and not subject to appeal

Grant Recipient Obligations

If successful, be prepared to:

• Submit biannual reports tracking progress against planned timeline (required for release of second payment)
• Submit an abstract to the EuroELSO Annual Congress within 2 years (mandatory - failure can penalize future applications from your team)
• Provide a final report at end of 18-month project period
• Acknowledge EuroELSO funding in all publications and presentations

Payment Structure

• 50% paid at project start
• 40% paid when 50% of project objectives are met (assessed via biannual reports)
• 10% paid following final report approval by Steering Committee

Strategic Advice from Successful Applicant

Teresa Lee from Imperial College London, who received €15,000 for the HITEC study on immunothrombosis in ECMO patients, exemplifies a successful application with: clear clinical question, measurable biomarkers, prospective recruitment plan, and alignment with EuroELSO's priority theme of haematological impact of ECMO.

Key Takeaways for Grant Writers

1. Align with working group themes: Projects aligned with EuroELSO's established working groups (infection, neurological outcomes, simulation/AI, haematological impact, ECPR, innovation) may have strategic advantage

1. Demonstrate ELSO centre connection: Your host institution must be an active ELSO centre or affiliated with one - confirm this before applying

1. Balance pediatric and adult applications: With at least one grant designated for pediatric and one for adult practice, consider which category your project fits and potential competition

1. Write for three assessors: Your application will be independently scored by at least three people - clarity and completeness matter

1. Justify every cost: Budget scrutiny is significant - show that resources are both sufficient and reasonable, with no expectation of additional funding

1. Plan for 18 months: Timeline must be realistic for completion within 18 months, with clear milestones for biannual reporting

1. Commit to dissemination: Be prepared to present findings at EuroELSO Congress within 2 years - this is not optional and affects future eligibility

1. Use feedback constructively: With 10-day turnaround on feedback for unsuccessful applications, reapplication is feasible - use the narrative feedback to strengthen your next submission

Similar Funders

These funders have a similar focus and geographic reach:

• European Society of Endocrinology
• European Society for Neurochemistry
• ACTION MEDICAL RESEARCH
• Association of Physicians of Great Britain and Ireland

References

• EuroELSO Grants Programme: https://euroelso.net/euroelso-grants/
• UK Charity Commission Register - EUROELSO ASSOCIATES (1153778): https://register-of-charities.charitycommission.gov.uk/charity-search/-/charity-details/5036996/financial-history
• EuroELSO Official Website: https://euroelso.net/
• EuroELSO Steering Committee: https://euroelso.net/steering-committee/
• EuroELSO Working Groups: https://euroelso.net/working-groups/
• EuroELSO Vision and Mission: https://euroelso.net/vision-and-mission/
• Call for EuroELSO Grants 2022-2023: https://www.euroelso.net/call-for-euroelso-grants-2022-2023/
• Imperial College London EuroELSO Grant Success Story: https://blogs.imperial.ac.uk/surgeryandcancer/2022/07/26/euroelso-grant-success/
• ELSO About EuroELSO: https://www.elso.org/aboutus/chapters/euroelso.aspx